查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552565

藥物傳輸和基因輸送設備的市場規模、佔有率和趨勢分析報告：按給藥途徑、媒介、地區和細分市場預測，2024-2030年

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

藥物傳輸和基因傳輸設備市場成長和趨勢：

根據 Grand View Research, Inc. 的最新報告，預計 2030 年全球藥物遞送和基因遞送市場規模將達到 12.2 億美元，2024 年至 2030 年複合年成長率為 9.0%。

市場成長的驅動力是市場參與企業增加投資開發創新的藥物輸送系統，以滿足患者需求並以最小的原料藥數量提高生物有效性。此外，鑑於基因療法在治療多種疾病方面的高成長潛力，對基因遞送系統研究和開發的日益關注預計將刺激未來市場的成長。

隨著患者偏好的變化，藥物輸送系統也不斷發展。例如，荷爾蒙補充療法最初以錠劑形式廣泛使用，現在以預填充式注射器、貼片、避孕環、凝膠和噴霧劑的形式提供。開發各種形式的交付系統的主要目的是提高易用性。在設計藥物輸送系統時，也考慮輸送系統的美觀、價格和原料藥的數量等因素。

藥物傳輸和基因輸送設備市場報告亮點：

  • 2023年，口服劑型細分市場佔據主導地位，由於其方便和易於給藥，佔據了最大的收益佔有率，達到52.7%。
  • 由於危及生命的疾病的盛行率不斷上升以及注射給藥裝置的進步，預計注射劑領域在預測期內的複合年成長率將達到 11.0%。
  • 2023年，由於患有慢性病的人數不斷增加，北美以54.0%的銷售佔有率主導藥物和基因遞送市場。
  • 亞太地區藥物輸送市場預計在預測期內將成長。這種成長是由於生活方式的改變以及酒精和菸草消費量的增加導致心臟病、糖尿病和癌症等慢性疾病的盛行率不斷增加。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章藥物傳輸和基因傳輸設備市場的變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 藥物傳輸與基因傳遞設備市場分析工具
    • 波特的分析
    • PESTEL分析

第 4 章 藥物傳遞與基因傳遞設備市場：依給藥途徑的估計與趨勢分析

  • 細分儀表板
  • 藥物傳遞與基因傳遞裝置：2023 年及 2030 年依給藥途徑進行的前景分析
  • 口服
  • 吸入
  • 經皮的
  • 注射
  • 眼科
  • 鼻腔
  • 外用

第5章藥物傳輸與基因傳遞設備市場：向量估計與趨勢分析

  • 細分儀表板
  • 藥物傳輸與基因傳遞設備市場：Vector 分析，2023 年和 2030 年
  • 病毒
  • 非病毒

第6章 藥物傳輸與基因傳遞設備市場：區域估計與趨勢分析

  • 2023 年和 2030 年藥物傳輸和基因輸送設備市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Uniqure NV,
    • SiBiono GeneTech Co.
    • Epeius Biotechnologies Corporation
    • Shanghai Sunway Biotech Co., Ltd
    • Pfizer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Johnson and Johnson
    • Novartis AG
    • Bayer AG
    • Becton, Dickinson and Company
簡介目錄
Product Code: GVR-1-68038-238-9

Drug And Gene Delivery Devices Market Growth & Trends:

The global drug and gene delivery devices market size is expected to reach USD 1.22 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.

Drug And Gene Delivery Devices Market Report Highlights:

  • In 2023, the oral segment dominated the market and accounted for the largest revenue share of 52.7%, owing to its convenience and ease of administration.
  • The injectable segment is expected to witness the fastest CAGR of 11.0% during the forecast period, fueled by increasing prevalence of life-threatening diseases and advancement in injectable drug delivery devices.
  • In 2023, North America dominated the drug and gene delivery devices market with a revenue share of 54.0%, owing to the rising number of people suffering from chronic diseases.
  • The drug and gene delivery devices market in Asia Pacific is projected to witness growth during the forecast period. The growth can be attributed to the increasing prevalence of chronic diseases such as heart disease, diabetes and cancer owing to the changing lifestyle, increase in consumption of alcohols and cigarettes.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Drug and Gene Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Drug and Gene Delivery Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Drug and Gene Delivery Devices Market: Route of Administration Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Drug and Gene Delivery Devices: Route of Administration Outlook Analysis, 2023 & 2030 (USD Million)
  • 4.3. Oral
    • 4.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Inhalation
    • 4.4.1. Inhalation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Transdermal
    • 4.5.1. Transdermal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Injectable
    • 4.6.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Ocular
    • 4.7.1. Ocular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Nasal
    • 4.8.1. Nasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Topical
    • 4.9.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug and Gene Delivery Devices Market: Vector Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Drug and Gene Delivery Devices Market: Vector Analysis, 2023 & 2030 (USD Million)
  • 5.3. Viral
    • 5.3.1. Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Non-Viral
    • 5.4.1. Non-Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Drug and Gene Delivery Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Drug and Gene Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Uniqure N.V.,
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. SiBiono GeneTech Co.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Epeius Biotechnologies Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Shanghai Sunway Biotech Co., Ltd
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Pfizer, Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. F. Hoffmann-La Roche Ltd.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
    • 7.4.7. Johnson and Johnson
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Novartis AG
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Bayer AG
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Becton, Dickinson and Company
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives